Search research articles
Contact Us
Filters
Showing results (81-90 of 138) with videos related to
Page
of 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2017
The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting
G Dranitsaris, A Molassiotis, M Clemons, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer
M Aapro, F Andre, K Blackwell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2004
Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG)
L Biganzoli, A Goldhirsch, C Straehle, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting. Experience in eighty-four patients
J F Kessler, D S Alberts, P M Plezia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 28, 2014
Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis
M Aapro, V Moebus, U Nitz, et al.
ESMO Open
|
September 18, 2025
From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development
S Champiat, K Ouali, A Laparra, et al.
Breast (Edinburgh, Scotland)
|
March 5, 2013
Should all postmenopausal patients with hormone receptor-positive breast cancer receive initial therapy with aromatase inhibitors?
M Aapro, C J H van de Velde, C Markopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2018
Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane
M Martin, M Campone, I Bondarenko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2015
Reply to letter to the editor 'Primum non nocere' by Templeton and Šeruga
M Aapro, V Moebus, U Nitz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 21, 2023
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents
Jørn Herrstedt, L Celio, P J Hesketh, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 138) with videos related to
Sort By:
Page
of 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2017
The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting
G Dranitsaris, A Molassiotis, M Clemons, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer
M Aapro, F Andre, K Blackwell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2004
Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG)
L Biganzoli, A Goldhirsch, C Straehle, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting. Experience in eighty-four patients
J F Kessler, D S Alberts, P M Plezia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 28, 2014
Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis
M Aapro, V Moebus, U Nitz, et al.
ESMO Open
|
September 18, 2025
From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development
S Champiat, K Ouali, A Laparra, et al.
Breast (Edinburgh, Scotland)
|
March 5, 2013
Should all postmenopausal patients with hormone receptor-positive breast cancer receive initial therapy with aromatase inhibitors?
M Aapro, C J H van de Velde, C Markopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2018
Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane
M Martin, M Campone, I Bondarenko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2015
Reply to letter to the editor 'Primum non nocere' by Templeton and Šeruga
M Aapro, V Moebus, U Nitz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 21, 2023
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents
Jørn Herrstedt, L Celio, P J Hesketh, et al.
Page
of 14